Omeprazole extended-R and 1 more item
Closed Solicitation Posted
- Solicitation number
- SPE2DP27Q0003
- Agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- Not on record
- PSC
- 6505 Drugs And Biologicals
- More information
Notice details come from DLA DIBBS. Updated .
About this opportunity
The Defense Logistics Agency Troop Support Medical, through DLA office SPE2DP, seeks quotes for Omeprazole Extended-Release capsules under NSN 6505-01-314-2716, with quotations due October 22, 2026. The Set Aside line reads "No Set-Aside Used," so the procurement is open to all sources.
The solicitation contains two line items, each for 4 BT, with delivery within 15 days under purchase requests 7017890913 and 7018491913. Quotes must be submitted via DIBBS. Terms are FOB destination with inspection at destination. Quoters must provide commercial pricing, state whether prices come from published catalogs or internal price lists, and confirm FOB destination terms. The attachment describes firm fixed per-bottle pricing for 30-count units. Delivery is to Fort Bliss, Texas and Weslaco, Texas.
The product must meet USP controlled room temperature storage (20-25 degrees Celsius), comply with Medical Marking Standard No. 1 for labeling, and carry an 18-month shelf life that is non-extendable. Shipment must use traceable means and not parcel post. The attachment lists four approved manufacturers: Astra Pharmaceutical Products Inc., Sandoz Inc., Amerisource Health Services LLC, and Golden State Medical Supply Inc.
The solicitation incorporates the DLA Master Solicitation (Version 105, dated May 20, 2026) and numerous FAR and DFARS provisions covering cybersecurity, buy-American requirements, WAWF payment, and representations and certifications. RapidGate security enrollment may be required for base access, estimated at approximately $250 per company plus $200 per enrolled driver for one year. The PSC is 6505, Drugs and Biologicals.
Notice text
DLA request for quotation SPE2DP27Q0003, issued by DLA office SPE2DP through DIBBS. Quotes are due by 10/22/2026. Set-aside: No Set-Aside Used. FOB Destination. Inspection at Destination. Items: line 0001, OMEPRAZOLE EXTENDED-R, NSN 6505-01-314-2716, 4 BT, delivery in 15 days, PR 7017890913; line 0002, OMEPRAZOLE EXTENDED-R, NSN 6505-01-314-2716, 4 BT, delivery in 15 days, PR 7018491913. Quotes must be submitted via DIBBS.
Files
| File | Type | Posted |
|---|---|---|
| SPE2DP27Q0003.pdf |
Similar open opportunities
| Opportunity | Agency | Set-aside | Responses due |
|---|---|---|---|
| Omeprazole extended-R | Medical Supply Chain | No set-aside | |
| Omeprazole extended-R and 1 more item | Medical Supply Chain | No set-aside | |
| Omeprazole extended-R and 6 more items | Medical Supply Chain | No set-aside | |
| Famotidine tablets | Medical Supply Chain | No set-aside | |
| Famotidine tablets | Medical Supply Chain | No set-aside |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity